SMi are proud to present their 9th annual Point of Care Diagnostics: Market Opportunities and Technology Trends24th and 25th of October, 2012. conference, scheduled for the
With point of care constantly at the forefront of the biotechnology and healthcare markets, the need for up to date information on both the emerging technologies, and the market opportunities is paramount. Rapid testing in all areas of healthcare, from primary care to the emergency services is becoming increasingly expected, and successful point of care technology can revolutionise our ability to create this fast, personalised medicine. Challenges still remain, however, about the logistics of companion diagnostics, the legitimacy of patient independence and the redistribution of profit within the healthcare technology sector.
Why should you attend this event?
Our expert speaker line-up also includes:
ChemiFast is a new chemiluminescence substrate that is sensitive and produces a signal that is stable for up to 24 hours, making i....
The KingFisher Duo nucleic acid purification system is a low- to medium-throughput package, which includes the KingFisher magnetic....
The new Human Stemcca
The rProtein A GraviTrap
© 2013 Bioscreening.com